Showing results (171-180 of 204) with videos related to

Sort By:
Pageof 21
RMD Open|November 30, 2018
Patient-reported outcomes and safety in patients undergoing synovial biopsy: comparison of ultrasound-guided needle biopsy, ultrasound-guided portal and forceps and arthroscopic-guided synovial biopsy techniques in five centres across EuropeSøren Andreas Just, Frances Humby, Hanne Lindegaard, et al.
Rheumatology (Oxford, England)|March 3, 2019
Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritisElizabeth M A Hensor, Paul McKeigue, Stephanie F Ling, et al.
Rheumatology (Oxford, England)|March 22, 2003
FcgammaRIIIA-158V and rheumatoid arthritis: a confirmation studyA W Morgan, V H Keyte, S J Babbage, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 20, 2018
A Multicenter Study of the Validity and Reliability of Responses to Hand Cold Challenge as Measured by Laser Speckle Contrast Imaging and Thermography: Outcome Measures for Systemic Sclerosis-Related Raynaud's PhenomenonJack D Wilkinson, Sarah A Leggett, Elizabeth J Marjanovic, et al.
European Heart Journal. Imaging Methods and Practice|June 12, 2026
EACVI survey on the use of multi-modality cardiovascular imaging in immune-mediated inflammatory diseasesMarta Peverelli, Beth Whittington, Theo Pezel, et al.
Annals of the Rheumatic Diseases|October 8, 2013
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)Maxime Dougados, Martin Soubrier, Anna Antunez, et al.
Annals of the Rheumatic Diseases|December 20, 2023
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023Kevin L Winthrop, Philip Mease, Andreas Kerschbaumer, et al.
Lancet (London, England)|February 16, 2024
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trialAndrew P Cope, Marianna Jasenecova, Joana C Vasconcelos, et al.
Ebiomedicine|November 13, 2022
Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunityJames I Robinson, Md Yuzaiful Md Yusof, Vinny Davies, et al.
Lancet (London, England)|January 24, 2021
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trialFrances Humby, Patrick Durez, Maya H Buch, et al.
Pageof 21